These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5718328)

  • 1. [Preparation of antihemophilic kryoprecipitates (AHKP) from fresh plasma and its use in hemophilia A].
    Brüster H
    Monatsschr Kinderheilkd (1902); 1968 Jun; 116(6):388-90. PubMed ID: 5718328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antihemophilic cryoprecipitate from fresh plasma and its use in hemophilia A].
    Brüster H; Glassner K; Riech PC
    Dtsch Med Wochenschr; 1967 Oct; 92(41):1859-66. PubMed ID: 6057144
    [No Abstract]   [Full Text] [Related]  

  • 3. The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma: characterization and further data on preparation and clinical trial.
    Hershgold EJ; Pool JG; Pappenhagen AR
    J Lab Clin Med; 1966 Jan; 67(1):23-32. PubMed ID: 5321736
    [No Abstract]   [Full Text] [Related]  

  • 4. The preparation of a human plasma fraction by cryoprecipitation and its use in haemophilia.
    Waumans P; Van Itterbeek R; Verstraete M
    Acta Clin Belg; 1968; 23(3):139-52. PubMed ID: 5713674
    [No Abstract]   [Full Text] [Related]  

  • 5. [Colonic resection in severe hemophilia A under the protection of antihemophilic cryoprecipitates].
    Brüster H; Ringler W; Glassner K; Riech PC; Himmelbach E
    Dtsch Med Wochenschr; 1969 Sep; 94(36):1799-802. PubMed ID: 5806910
    [No Abstract]   [Full Text] [Related]  

  • 6. [in vivo reappearance of injected cryoprecopitate (factor VIII concentrates) in patients with hemophilia A].
    Kuble M; Wegner H; Cron D
    Z Gesamte Inn Med; 1973 Oct; 28(20):608-14. PubMed ID: 4767194
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term follow-up of consumption of plasma, blood and antihemophilic globulin in patients with hemophilia].
    Pudlák P; Horák J
    Vnitr Lek; 1968 Jan; 15(1):1-8. PubMed ID: 5720983
    [No Abstract]   [Full Text] [Related]  

  • 8. Human plasma and plasma fractions as sources of factor VIII (antihaemophilic factor).
    Verstraete M; Olislaegers P; Van Itterbeek H; Waumans P; Lust A
    Vox Sang; 1969 Apr; 16(4):382-97. PubMed ID: 5800592
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cryoprecipitation and dextran precipitation in obtaining factor VIII concentrates: results of redetecting antihemophilic globulin A in a patient].
    Kubel M; Wegner H; Liebe S
    Z Gesamte Inn Med; 1974 Mar; 29(6):236-40. PubMed ID: 4409090
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical use of a new glycine-precipitated antihemophilic fraction.
    Webster WP; Roberts HR; Thelin GM; Wagner RH; Brinkhous KM
    Am J Med Sci; 1965 Dec; 250(6):643-51. PubMed ID: 5846510
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of hemophilia A with a cryoprecipitated antihemophilic factor].
    Ollendorff P
    Ugeskr Laeger; 1969 May; 131(20):877-81. PubMed ID: 5795169
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 13. [The cryoprecipitate, plasmatic fraction rich in antihemophilic globulin (factor VIII). Its use in the treatment of hemophilia].
    Otto-Servais M; Hugues J
    Rev Med Liege; 1969 May; 24(10):401-7. PubMed ID: 5376503
    [No Abstract]   [Full Text] [Related]  

  • 14. A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors.
    Brinkhous KM; Shanbrom E; Roberts HR; Webster WP; Fekete L; Wagner RH
    JAMA; 1968 Aug; 205(9):613-7. PubMed ID: 5695099
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation of and clinical experience with antihemophilic factor concentrates.
    Johnson AJ; Karpatkin MH; Newman J
    Thromb Diath Haemorrh Suppl; 1968; 35():49-59. PubMed ID: 5317364
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of classical hemophilia with factor 8 concentrates.
    Waterbury L; Frenkel EP
    Clin Anesth; 1968; 3():288-97. PubMed ID: 4902367
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspects of the management of hemophilia in childhood. Availability of newer concentrates of antihemophilic factor failitates management.
    Strauss HS
    R I Med J; 1966 Aug; 49(8):466-8. PubMed ID: 5222119
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparin and factor VIII.
    Smit Sibinga CT; Das PC
    Scand J Haematol Suppl; 1984; 40():111-22. PubMed ID: 6433440
    [No Abstract]   [Full Text] [Related]  

  • 19. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM; Skinner SF; Kaneko JJ
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
    Shanbrom E; Thelin GM
    JAMA; 1969 Jun; 208(10):1853-6. PubMed ID: 5818829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.